Biomerica, Inc. (BMRA) financial statements and ratios from SEC XBRL: revenue $0.0B (TTM), net margin -84.8%, revenue growth 17.0% YoY. Income statement, balance sheet, cash flow, and valuation. First-party data.
| Revenue (latest FY) | $4.45M |
| Revenue (TTM) | $0.0B |
| Net Margin | -84.8% |
| Operating Margin (TTM) | -119.5% |
| Interest Coverage | -20435.1 |
| Revenue Growth (YoY) | 17.0% |
| EPS Growth (YoY) | -40.9% |
| Price / Book | 3.82 |
| Price / Sales | 2.26 |
| Altman Z-Score | -12.09 (distress) |
| Industry P/E (Pharmaceutical Products) | 17.2 |
| Sector P/E (Healthcare) | 21.6 |
BMRA overview · BMRA earnings · BMRA KPIs · BMRA documents · BMRA ownership · BMRA peers
Data sourced from U.S. SEC EDGAR XBRL filings. Not personalized investment advice.